Analysis of DNA damage induced by aflatoxin B1 in Dunkin-Hartley guinea pigs

Mycopathologia

Volumn 163, Issue 5, 2007, Pages 275-280

  Miranda, D D C ^a   Arcari D P ^a   Ladeira, M S P ^b   Calori Domingues, M A ^c   Romero, A C ^c   Salvadori, D M F ^b   Gloria, E M ^c   Pedrazzoli Jr , J ^a   Ribeiro, M L ^a  

^a UNIVERSIDADE SÃO FRANCISCO   (Brazil)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Aflatoxin B1; Comet Assay; Oxidative DNA damage

Indexed keywords

AFLATOXIN B1; CARCINOGEN; MUTAGENIC AGENT;

ANIMAL; ARTICLE; COMET ASSAY; DNA DAMAGE; DRUG EFFECT; FOOD CONTAMINATION; GUINEA PIG; LIVER CELL; LYMPHOCYTE; MALE; METABOLISM;

AFLATOXIN B1; ANIMALS; CARCINOGENS; COMET ASSAY; DNA DAMAGE; FOOD CONTAMINATION; GUINEA PIGS; HEPATOCYTES; LYMPHOCYTES; MALE; MUTAGENS;

ANIMALIA; CAVIA;

EID: 34248196544     PISSN: 0301486X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11046-007-9014-y     Document Type: Article

References (26)

1. Vainio H, Heseltine E, Wilbourn J. Report on an IARC. Working group meeting on some naturally occurring substances. Int. J. Cancer 1993;53:535-7.
2. Henry SH, Bosch FX, Troxell TC, Bolger PM. Policy forum: public health. Reducing liver cancer-global control of aflatoxin. Science 1999;286:2453-4.
3. Wogan GN. Aflatoxins as risk factors for hepatocellular carcinoma in humans. Cancer Res 1992;52:2114-8.
4. Groopman JD, Wang JS, Scholl P. Molecular biomarkers for aflatoxins: from adducts to gene mutations to human liver cancer. Can. J. Physiol Pharmacol 1996;74:203-9.
5. Smela ME, Currier SS, Bailey EA, Essigmann JM. The chemistry and biology of aflatoxin B(1): from mutational spectrometry to carcinogenesis. Carcinogenesis 2001;22:535-45.
6. Shimada T, Guengerich FP. Evidence for cytochrome P-450NF, the nifedipine oxidase, being the principal enzyme involved in the bioactivation of aflatoxins in human liver. Proc. Natl. Acad. Sci. U. S. A 1989;86:462-5.
7. Ueng YF, Shimada T, Yamazaki H, Guengerich FP. Oxidation of aflatoxin B1 by bacterial recombinant human cytochrome P450 enzymes. Chem Res Toxicol 1995;8:218-25.
8. Goldman R, Shields PG. Food mutagens. J Nutr 2003;133(Suppl 3):965S-73S.
9. Essigmann JM, Croy RG, Nadzan AM, Busby WF, Reinhold VN, Buchi G, Wogan GN. Structural identification of the major DNA adduct formed by aflatoxin B1 in vitro. Proc Natl Acad Sci U S A 1977;74:1870-4.
10. Groopman JD, Croy RG, Wogan GN. In vitro reactions of aflatoxin B1-adducted DNA. Proc Natl Acad Sci U S A 1981;78:5445-9.
11. Bailey EA, Iyer RS, Stone MP, Harris TM, Essigmannm JM. Mutational properties of the primary aflatoxin B1-DNA adduct. Proc Natl Acad Sci U S A 1996;93:1535-9.
12. Groopman JD, Kensler TW. The light at the end of the tunnel for chemical-specific biomarkers: daylight or headlight? Carcinogenesis 1999;20:1-11.
13. Tice RR, Agurell E, Anderson D, Burlinson B, Hartmann A, Kobayashi H, Miyamae Y, Rojas E, Ryu JC, Sasaki YF. 2000 Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ Mol Mutagen 35:206-21.
14. Hartmann A, Agurell E, Beevers C, Brendler-Schwaab S, Burlinson B, Clay P, Collins A, Smith A, Speit G, Thybaudm V, Tice RR. Recommendations for conducting the in vivo alkaline Comet assay. 4th International Comet Assay Workshop. Mutagenesis 2003;18:45-51.
15. Soares LM, Rodriguez-Amaya DB. Survey of aflatoxins, ochratoxin A, zearalenone, and sterigmatocystin in some Brazilian foods by using multi-toxin thin-layer chromatographic method. J Assoc Off Anal Chem 1989;72:22-6.
16. Ross PF, Rice LG, Plattner RD, Osweiler GD, Wilson TM, Owens DL, Nelson HA, Richard JL. Concentrations of fumonisin B1 in feeds associated with animal health problems. Mycopathologia 1991;114:129-35.
17. Plappert U, Barthel E, Raddatz K, Seidel HJ. Early effects of benzene exposure in mice. Hematological versus genotoxic effects. Arch Toxicol 1994;68:284-90.
18. Singh NP, McCoy MT, Tice RR, Schneider EL. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res 1988;175:184-91.
19. Williams JH, Phillips TD, Jolly PE, Stiles JK, Jolly CM, Aggarwal D. Human aflatoxicosis in developing countries: a review of toxicology, exposure, potential health consequences, and interventions. Am J Clin Nutr 2004;80:1106-22.
20. Setlow RB. Human cancer: etiologic agents/dose responses/DNA repair/cellular and animal models. Mutat Res 2001;477:1-6.
21. Bressac B, Kew M, Wands J, Ozturk M. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature 1991;351:429-31.
22. Hsu IC, Metcalf RA, Sun T, Welsh JA, Wang NJ, Harris CC. Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature 1991;350:427-8.
23. Abd-Allah GA, el-Fayoumi RI, Smith MJ, Heckmann RA, O'Neill KL. A comparative evaluation of aflatoxin B1 genotoxicity in fish models using the Comet assay. Mutat Res 1999;446:181-8.
24. Miele M, Donato F, Hall AJ, Whittle H, Chapot B, Bonatti S, De Ferrari M, Artuso M, Gallerani E, Abbondandolo A, Montesano R, Wild CP. Aflatoxin exposure and cytogenetic alterations in individuals from the Gambia, West Africa. Mutat Res 1996;349:209-17.
25. Anderson D, Yu TW, Hambly RJ, Mendy M, Wild CP. Aflatoxin exposure and DNA damage in the comet assay in individuals from the Gambia, West Africa. Teratog Carcinog Mutagen 1999;19:147-55.
26. Jeffrey AM, Williams GM. Risk assessment of DNA-reactive carcinogens in food. Toxicol Appl Pharmacol 2005;207:628-35.